MMP-2 can be considered a biomarker of HF, as higher plasma MMP-2 levels were found in patients with congestive HF, resulting from different etiologies (acute myocardial infarction, dilated cardiomyopathy and valvular disease). This evidence concerns the gene MMP2 and hydrops fetalis.